Hisamitsu Pharmaceutical Co., Inc. (4530.T)

Home
4530.T
Financials

3948 (JPY) • At close September 19, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004
Revenue Numbers are in millions	141,706	128,330	120,193	114,510	140,992	143,408	147,870	145,925	161,852	156,743	150,635	142,772	137,794	137,184	129,834	124,655	119,061	109,791	102,665	83,545
Cost of Revenue Numbers are in millions	62,735	55,630	50,126	45,337	53,388	54,727	55,688	53,155	58,319	57,063	55,471	51,659	46,785	47,697	42,659	39,884	36,101	32,906	29,840	24,724
Gross Profit Numbers are in millions	78,971	72,700	70,067	69,173	87,604	88,681	92,182	92,770	103,533	99,680	95,164	91,113	91,009	89,487	87,175	84,771	82,960	76,885	72,825	58,821
Gross Profit Ratio Numbers are in millions	0.557	0.567	0.583	0.604	0.621	0.618	0.623	0.636	0.64	0.636	0.632	0.638	0.66	0.652	0.671	0.68	0.697	0.7	0.709	0.704
Reseach & Development Expenses Numbers are in millions	8,614	9,785	10,613	10,766	10,504	13,032	15,076	14,378	14,965	13,718	13,924	12,662	0	0	0	0	0	0	0	0
General & Administrative Expenses Numbers are in millions	25,290	23,218	20,582	20,203	22,872	24,165	23,865	25,068	29,415	30,300	31,360	84	0	0	0	0	0	0	0	0
Selling & Marketing Expenses Numbers are in millions	31,899	28,096	29,535	27,532	31,499	29,204	26,895	26,088	30,355	34,189	29,883	28,325	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	57,189	51,314	50,117	47,735	54,371	53,369	50,760	51,156	59,770	64,489	61,243	52,409	0	0	0	0	0	0	0	0
Other Expenses Numbers are in millions	498	197	417	414	330	382	1,013	482	355	573	509	470	740	702	814	879	828	779	1,106	276
Operating Expenses Numbers are in millions	65,803	61,099	60,730	58,501	64,875	66,401	65,836	66,464	75,802	79,153	76,040	65,786	65,070	61,292	58,589	52,239	53,888	50,754	50,054	37,324
Operating Income Numbers are in millions	13,168	11,599	9,337	10,671	22,727	22,278	26,345	26,306	27,730	20,527	19,123	25,326	25,937	28,193	28,585	32,532	29,071	26,134	22,770	21,495
Operating Income Ratio Numbers are in millions	0.093	0.09	0.078	0.093	0.161	0.155	0.178	0.18	0.171	0.131	0.127	0.177	0.188	0.206	0.22	0.261	0.244	0.238	0.222	0.257
Total Other Income Expenses Net Numbers are in millions	6,018	4,511	3,618	1,524	3,426	3,392	1,348	3,678	192	8,889	14,604	6,665	6,440	7,909	3,262	-324	1,134	-214	1,736	401
Income Before Tax Numbers are in millions	19,186	16,113	12,956	12,197	26,155	25,673	27,694	29,984	27,922	29,416	33,727	31,991	32,379	36,104	31,848	32,208	30,206	25,917	24,507	21,898
Income Before Tax Ratio Numbers are in millions	0.135	0.126	0.108	0.107	0.186	0.179	0.187	0.205	0.173	0.188	0.224	0.224	0.235	0.263	0.245	0.258	0.254	0.236	0.239	0.262
Income Tax Expense Numbers are in millions	4,754	3,987	3,093	2,764	7,244	6,294	8,367	9,443	9,993	10,431	12,166	13,409	13,755	14,975	13,284	13,020	11,477	10,058	10,003	8,855
Net Income Numbers are in millions	13,969	11,742	9,658	9,250	18,694	19,204	19,119	20,395	17,784	18,784	21,357	18,809	18,439	20,956	18,423	19,120	18,663	15,847	14,448	12,873
Net Income Ratio Numbers are in millions	0.099	0.091	0.08	0.081	0.133	0.134	0.129	0.14	0.11	0.12	0.142	0.132	0.134	0.153	0.142	0.153	0.157	0.144	0.141	0.154
EPS Numbers are in millions	181.61	148	118.92	113.21	227.58	230.08	228.35	241.27	208.81	219.28	249.3	219.56	215.09	241.8	210.78	215.61	210.45	178.4	159.75	141.3
EPS Diluted Numbers are in millions	181.41	147.87	118.84	113.1	227.3	229.86	228.35	241.15	208.76	219.28	249.3	219.56	215.09	241.8	210.78	215.61	210.45	178.4	159.75	141.3
EBITDA Numbers are in millions	18,340	21,017	16,978	16,162	29,897	30,406	34,282	35,586	36,586	36,137	36,436	40,682	40,485	40,513	38,963	39,374	35,767	32,263	29,493	25,220
EBITDA Ratio Numbers are in millions	0.129	0.164	0.141	0.141	0.212	0.212	0.232	0.244	0.226	0.231	0.242	0.285	0.294	0.295	0.3	0.316	0.3	0.294	0.287	0.302

Hisamitsu Pharmaceutical Co., Inc.

TSE:4530.T Add to watchlist

TSE:4530.T